MedTrace Logo

Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity Program

NCT06230016 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2026-05-20

No results posted yet for this study

Summary

Adapted physical activity session with a formed professional is proposed in standard care since 2022 in the immuno-hematological service to all children with newly diagnosed cancer or relapse.

The aim of this study is to keep the children in the APA programm during all the treatment lenght.

This study aims to evaluate by questionnaires the motivation keys and restraint from children and parents before the APA program starts (at diagnosis or relapse if not previously participating to an APA programm) and after 4 to 6 months of APA programm.

The final expected fallout is to enhance children adhesion to long term APA program by implementing tools in current practice to overcome restraints from young patients and their parents

Conditions

  • Childhood Cancer
  • Adapted Physical Activity

Interventions

OTHER

questionnaires

human and social science questionnaire (specifically designed by the expert lab of Grenoble) on motivation and restraint perceived by patient and parents, elaborated especially for this study. Questionnaire administred before the start of current care APA programm and after 4 to 6 months.

OTHER

PedsQL quality of life questionnaires

validated PedsQL (The Pediatric Quality of Life Inventory) questionnaires administred to children (if adequate) and parents before the start of current care APA programm and after 4 to 6 months

Sponsors & Collaborators

  • University Grenoble Alps

    collaborator OTHER

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Leila Gofti Laroche, MD · CHU Grenoble Alpes

Eligibility

Min Age
3 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-16
Primary Completion
2026-02-27
Completion
2026-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06230016 on ClinicalTrials.gov